Literature DB >> 24392539

Newer basal insulin analogues: degludec, detemir, glargine.

Sanjay Kalra1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24392539

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


× No keyword cloud information.
  6 in total

Review 1.  Clinical use of Insulin Degludec: Practical Experience and Pragmatic Suggestions.

Authors:  Sanjay Kalra; Yashdeep Gupta
Journal:  N Am J Med Sci       Date:  2015-03

2.  Basal insulin analogues in the treatment of diabetes mellitus: What progress have we made?

Authors:  Sanjay Kalra
Journal:  Indian J Endocrinol Metab       Date:  2015-04

3.  Insulin degludec: a significant advancement in ultralong-acting Basal insulin.

Authors:  Sanjay Kalra
Journal:  Diabetes Ther       Date:  2013-11-20       Impact factor: 2.945

4.  EADSG Guidelines: Insulin Therapy in Diabetes.

Authors:  Bahendeka Silver; Kaushik Ramaiya; Swai Babu Andrew; Otieno Fredrick; Sarita Bajaj; Sanjay Kalra; Bavuma M Charlotte; Karigire Claudine; Anthony Makhoba
Journal:  Diabetes Ther       Date:  2018-03-05       Impact factor: 2.945

Review 5.  Recombinant Human Insulin in Global Diabetes Management - Focus on Clinical Efficacy.

Authors:  Jean Claude Mbanya; Juergen Sandow; Wolfgang Landgraf; David R Owens
Journal:  Eur Endocrinol       Date:  2017-04-03

6.  Basal Insulin Inadequacy versus Failure - Using Appropriate Terminology.

Authors:  Sanjay Kalra; Yashdeep Gupta
Journal:  Eur Endocrinol       Date:  2015-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.